Eko Low Ejection Fraction Tool (ELEFT) vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Eko Low Ejection Fraction Tool (ELEFT)
by Eko Health
VS
eMurmur Heart AI
by eMurmur

AI Verdict

Tool A (ELEFT) is specifically designed for the early detection of low ejection fraction, integrating exclusively with Eko digital stethoscopes. Tool B (eMurmur Heart AI) offers a broader auscultation analysis, detecting heart murmurs and lung sounds, and is hardware-agnostic with strong telehealth capabilities. Therefore, the choice depends on whether the primary need is specific low ejection fraction screening with Eko hardware or a more comprehensive, flexible auscultation analysis platform.

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary objective is rapid, AI-powered screening for low ejection fraction (LVEF ≤ 40%), a key indicator of heart failure, during routine physical examinations. This tool is ideal for clinicians using Eko digital stethoscopes who need to quickly assess heart failure risk at the point of care, especially in settings where advanced diagnostic tools like echocardiography are not readily available.

View Eko Low Ejection Fraction Tool (ELEFT) →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if you require a comprehensive, hardware-agnostic platform for automated analysis of both heart and lung sounds, including detailed murmur detection and hemodynamic insights. This solution is particularly well-suited for telehealth, remote monitoring, and situations where flexibility across various digital stethoscopes and mobile access are critical for screening, follow-up, and specialist consultations.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Low Ejection Fraction Tool (ELEFT) eMurmur Heart AI
Pricing Unknown Contact for quote
Deployment Unknown Web-based, Mobile App, API integration
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI offers greater flexibility with its hardware-neutral platform, supporting various digital stethoscopes, mobile apps, and web portals. This broad compatibility and accessibility across different devices and settings enhance its overall usability for diverse clinical workflows. Eko's tool is tightly integrated with its own hardware, which can be less flexible.

Clinical Value

Tie

Both tools provide significant clinical value. Eko's ELEFT offers critical early detection of low ejection fraction, directly addressing heart failure risk. eMurmur Heart AI provides a broader diagnostic and monitoring capability by analyzing both heart and lung sounds, detecting various murmurs, and offering hemodynamic insights, which is valuable for a wider range of conditions.

Pricing & Value

Tie

Both Eko Low Ejection Fraction Tool (ELEFT) and eMurmur Heart AI require direct contact for pricing, indicating a lack of transparency. Without specific pricing details or publicly available information on their return on investment, it is not possible to definitively determine which tool offers better value.

Enterprise Readiness

eMurmur Heart AI

While both are FDA-cleared, HIPAA compliant, and offer BAAs, eMurmur Heart AI's hardware-neutral approach and its deployment across cloud, web, and mobile applications provide greater flexibility for integration into diverse enterprise environments. Its explicit support for telehealth and remote consultation further enhances its readiness for modern healthcare systems.

Innovation

eMurmur Heart AI

While ELEFT's rapid, AI-powered detection of low ejection fraction is a significant innovation for early heart failure intervention, eMurmur Heart AI demonstrates broader innovation. Its comprehensive analysis of both heart and lung sounds, detection of various murmurs, provision of hemodynamic insights, hardware neutrality, and advanced telehealth features like live streaming and data comparison for monitoring offer a wider scope of novel capabilities.

Support & Docs

Tie

Both Eko Health and CSD Labs (for eMurmur) provide standard support resources, including help centers, FAQs, and user manuals on their respective websites. Without more detailed information regarding the quality, responsiveness, or breadth of their support offerings, it is not possible to differentiate between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Low Ejection Fraction Tool (ELEFT) eMurmur Heart AI
Tool Name Eko Low Ejection Fraction Tool (ELEFT) eMurmur Heart AI
Company Eko Health CSD Labs
Primary AI Focus Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure. Automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights.
Stethoscope Compatibility Integrates with FDA-cleared Eko digital stethoscopes. Hardware-neutral and stethoscope agnostic platform compatibility.
Supported Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Internal Medicine, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and eMurmur Heart AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

ELEFT specifically aids in the early detection of low ejection fraction (LVEF u2264 40%), a key indicator of heart failure, by analyzing ECG and heart sound recordings during routine physical exams. It is suited for patients at risk for heart failure, including those with coronary artery disease, diabetes mellitus, cardiomyopathy, hypertension, and obesity. eMurmur Heart AI offers a broader analysis of heart and lung sounds, detecting and classifying pathologic and innocent heart murmurs, crackles, and wheezes, and providing hemodynamic insights. This makes it suitable for a wider range of auscultation needs, including screening, monitoring, and remote consultation across cardiology, internal medicine, and pulmonology specialties.
ELEFT integrates exclusively with FDA-cleared Eko digital stethoscopes and provides results in approximately 15 seconds during a physical exam, streamlining the process for early heart failure risk identification. In contrast, eMurmur Heart AI is hardware-neutral and stethoscope agnostic, supporting various digital stethoscopes, mobile apps, and web portals for flexible integration into screening, monitoring, and remote consultation workflows.
While ELEFT focuses on detecting low ejection fraction, eMurmur Heart AI provides automated analysis of S1, S2, murmurs, crackles, and wheezes, along with detection and classification of pathologic and innocent heart murmurs. It also offers hemodynamic insights, such as loudness ratios of S1, systole, S2, and diastole, and the ability to compare current and previous auscultation data for monitoring patient changes.
eMurmur Heart AI explicitly supports live streaming and remote auscultation for telehealth, offering mobile app and web portal access for remote consultation and secure storage of auscultation data. ELEFT is primarily designed for integration into routine physical exams with Eko stethoscopes, focusing on in-person early detection of low ejection fraction, though Eko's broader platform supports telehealth.
ELEFT processes and stores data in the cloud as part of the SENSORAu2122 platform, aiding in early identification of heart failure risk. eMurmur Heart AI offers recording, secure storage, and playback of auscultation data, along with the ability to compare current and previous data for monitoring, which supports longitudinal patient tracking and clinical review.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Low Ejection Fraction Tool (ELEFT) or eMurmur Heart AI

Backers

Who funded each tool's parent company.

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.